Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-02-25
1995-06-06
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 31557
Patent
active
054223695
ABSTRACT:
This invention relates a method for topical treatment of glaucoma or ocular hypertension by administration of an effective intraocular pressure reducing amont of a prostaglandin derivative of PGA, PGB, PGE and PGF, in which the omega chain contains a ring structure. The invention further relates to compositions comprising said prostaglandin derivatives in an ophthalmologically compatible carrier.
REFERENCES:
patent: 3956284 (1976-05-01), Hess et al.
patent: 3962312 (1976-06-01), Hayashi et al.
patent: 3987087 (1976-10-01), Bundy
patent: 4001300 (1977-01-01), Axen
patent: 4011262 (1977-03-01), Hess et al.
patent: 4115586 (1978-09-01), Miller, Jr.
patent: 4116988 (1978-09-01), Nelson
patent: 4117119 (1978-09-01), Kurono et al.
patent: 4128713 (1978-12-01), Schneider
patent: 4131738 (1978-12-01), Smith
patent: 4599353 (1986-07-01), Bito
patent: 4820728 (1989-04-01), Collins et al.
patent: 4824857 (1989-04-01), Goh et al.
patent: 4883819 (1989-11-01), Bito
patent: 5001153 (1991-03-01), Ueno et al.
patent: 5057621 (1991-10-01), Cooper et al.
Bill A (1975) "Blood Circulation and fluid dynamics in the eye". Physiol. Rew. 55: 383-417.
Biological Activities of 17-phenyl-18, 19 20-trinorprostaglandins in Prostaglandins 9 (1975) 9-18.
Bito L. Z., Camras C. B., Gum G. C. and Resul B. (1989), "The Ocular Hypotensive Effects and Side Effects of Prostaglandins on the Eyes of Experimental Animals" Progress in Clinical and Biological Research 312 Ed. L. Z. Bito and Johan Stjernschantz, A. R. Liss Inc., New York.
Bito, Baroody and Miranda (1987): Eicosanoids as a new class of ocular Hypotensive agents. The apparent therapeutic advantage of derived Prostaglandins of the A and B type as compared with primary prostaglandins of the E, F and D types", Experimental Eye Research, 44:825.
Supplement to Investigative Ophthalmology and Visual Science 22 39 (1982), L. Z. Bito, A. Draga, J. Blanco, and C. B. Camras, "Maintenance of Reduced Intraocular Pressure (IOP) for several months by topical application of prostaglandin (PG) E.sub.t to Eyes of Trained Cats".
Burke et al., "Prostaglandin F.sub.2.alpha. Effects on Rabbit IOP Negatively Correlate with Classical PGF.sub.2.alpha. -Receptor Stimulation Presented at ARVO annual meeting in Florida May 1-6, 1988.
Bundy, Chem Abst. 90:168141d, 1979.
Camras C. B., Bito L. Z. (1981). Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F.sub.2a ". Curr Eye Res 1:205-209.
Camras, C. B. Podos S. M. Rosenthal J. S. Lee P. Y., Severin C. H. (1987a). Multiple dosing of prostaglandin F.sub.2a or epinephrine on cynomolgus monkey eyes. I. Aqueous humor dynamics. Invest Ophthalmol Vis Sci 28:463-469.
Camras C. B., Bhuyan K. C. Podos S. M. Bhuyan D. K. Master R. W. P. (1987b) "Multiple Dosing of Prostaglandin F.sub.2.alpha. or epinephrine on cynomologus monkey eyes. II. Slitlamp biomicroscopy, aqueous humor analysis, and fluorescein angiography." Invest. Ophthamol. Vis. Sci. 28:921-926.
Camras C. B. Siebold E. C., Lustgarten J. S., Serle J. B., Frisch S. C., Podos S. M. Bito L. Z. (1988) "Reduction of IOP by prostaglandin F.sub.2.alpha. -1-isopropyl ester topically applied in glaucoma patients", Ophthalmology 95(Suppl.) 129.
Camras C. B. Bito L. Z. and Eakins K. E. (1977): "Reduction of intraocular pressure by prostaglandins applied to the eyes of concious rabbits", Invest Ophthamol Vis. Sci. 16:1125.
Crawford K., Kaufman P. L. and True Gabel, B. A. (1987), "Pilocarpine antagonizes PGF.sub.2.alpha. -induced ocular hypotension: Evidence for enhancement of uveoscleral outflow of PGF.sub.2.alpha. ". Invest. Ophthalmol. Vis. Sci. (Supp.) ARVO Abstracts 11.
Crawford, K. and Kaufman, P. L., (1987) "Pilocarpine Antagonizes Prostaglandin F.sub.2.alpha. -Induced Ocular Hypotension in Monkeys" Arch. Ophthalmology 105 1112.
Flach A. J., Elisason J. A. (1988). "Topical prostaglandin E.sub.2 effects on normal human intraocular pressure. J. Ocu. Pharmacol. 4:13-18.
Gabelt, B. and Kaufman, P. L. (1989)"Prostaglandin F.sub.2.alpha. Increases Uvelscleral Outflow in the Cynomologus Monkey", Exp. Eye Res. 49 389-402.
Giuffre (1985). "The Effects of prostaglandin F.sub.2.alpha. in the human eye." Graefes Arch Clin. Exp. Ophthalmol. 222:139-141.
Goldberg I. Kolker A. E. Kass M. A. and Becker B. (1980) "Dipivefrin: current concepts:, australia J. Ophthalmol., 8:147.
Granstrom, E., (1975) "Metabolism of 17-Phenyl-18,19,20-Trinor-Prostaglandin F.sub.2.alpha. in the Cynomolgus Monkey and the Human Female", Prostaglandins 9:19-45.
Kass, M. A., Posos, S. M., Moses, R. A., and Becker B. (1972): Prostaglandin E1 and aqueous humor dynamics", Invest Ophthalmology 11:1022.
Kass, M. A., Mandell Al, Goldberg I., Paine J. M. and Becker B (1979) "Dipivefrin" and epinephrine treatment of elevated intraocular pressure: A comparative Study", Arch Ophthalmol 97:1865.
Kaufman P. L. (1986), "Effects on intracamerally infused prostaglandins on outflow facility in cynomolgus monkey eyes with intact or retrodisplaced ciliary muscle." Exp. Eye Res. 43:819-827.
Kerstetter J. R., Brubaker R. F., Wilson S. E., Kullerstrand L. J. (1988). "Prostaglandin F.sub.2.alpha. -1-isopropylester lower intraocular pressure without decreasing aqueous humor flow". Am. J. Ophthalmol. 105:30-34.
Kerstetter J. R., Brubaker R. F., Wilson S. E. and Kullerstrand B. S. (1987): "Prostaglandin F2 alpha 1-isopropyl ester effects on aqueous humor dynamics in human subjects". Invest Ophthalmol Vis Sci Suppl, 28:266.
Kerstetter J. R., Brubaker R. F., Wilson S. E. and Kullerstrand L. (1988) "Prostaglandin F2.alpha.-1-Isopropylester Lowers Intracolor Pressure Without Decreasing Aqueous Humor Flow". Am. J. Ophthalmology 105:30-34.
Kirk-Othmar "Encyclopedia of Chemical Technology", 3d Ed. Supplement vol. 711-752 (1984).
Lee, P.-Y., Shae H. XZu L., Qu C.-K. (1988). The Effect of prostaglandin F.sub.2.alpha. on intraocular pressure in normotensive human subjects". Invest. Ophthalmol. Vis. Sci. 29:1474-1477.
Miller, "Biological Activities of 17-phenyl-18,19,20-trinorprostaglandins", Prostaglandins 9 9-18 (1975).
Nilsson S. F. E., Stjernschantz J. and Bill A. (1987) "PGF.sub.2.alpha. increase uveoscleral outflow. Invest. Ophthalmol Vis. Sci. Suppl. 284.
Prostaglandin F.sub.2.alpha. Effects on Rabbit IOP Negatively Correlate with Classical PGF.sub.2.alpha. -Receptor Stimulation Presented at AVRO annual meeting in Florida May 1-6, 1988, by Burke et al.
Prostaglandin F.sub.2.alpha. Effects on IOP Nth Classical PGF.sub.2.alpha. -Receptor Stimulation Presented in Eightly International Congress of Eye Research in San Francisco Sep. 4-8, 1988, by Woodward et al. (Burke is one of the Inventors).
Prostaglandin F.sub.2.alpha. Effects on Intraocular Pressure Negatively Correlate with FP-Receptor Stimulation Published in Invest. Ophthal. vol. 30 (8) (1989) 1838-1842 by Woodward et al. (Burke is one of the inventors).
Ritch, Shields and Krupin (1989): "The Glaucomas", C. V. Mosby, p. 561.
Starr, M. S. (1971) "Further studies on the effect of prostaglandin on intraocular pressure in the rabit, Exp. Eye, Res 11:170.
Villumsen J. Alm A. (1987): "The effect of prostaglandin F2.alpha. eye drops in open angle glaucoma", Invest. Ophthalmol. Vis. Sci. 28:378.
Villumsen J. Alm A. (1989) "Prostaglandin F.sub.2.alpha. isopropylester eye drops. Effects in normal human eyes." Br. J. Ophthalmol. 73:419-426.
Villumser J, Alm A., Soderstrom M. (1989) "Prostaglandin F2.alpha.-isopropylester Eye Drops: Effect on Intraocular Pressure in Open Angle Glaucoma", Brit. J. Ophthalmology 73, 975-979.
Wang R.-F., Cmamras C. B., Lee P.-Y., Podos S. M. and Bito L. Z. (1987) "The ocular hypotensive effects of Prostaglandins F2.alpha. isopropyl ester and A2 in glautomatous monkeys Invest. Ophthalmol Vis Sci ARVO Supl. 28:266.
Woodward et al., "Prostaglandin F.sub.2.alpha. Effects on IOP Negatively Correlate with Classical PGF.sub.2.alpha. -Receptor Stimulation Presented in Eightly International Congress of Eye Research in San Francisco Sep. 4-8, 1988.
Woodward et al. (1989) "Prostaglandin F.sub.2.alpha. Effects on
Resul Bahram
Stjernschantz Johan W.
Gerstl Robert
Kabi Pharmacia AB
LandOfFree
Prostaglanddin derivatives for the treatment of glaucoma or ocul does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglanddin derivatives for the treatment of glaucoma or ocul, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglanddin derivatives for the treatment of glaucoma or ocul will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-988014